BSBlessing Silaigwana

Blessing Silaigwana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Blessing Silaigwana has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ethics to inform decision-making

    by Sarah J.L. Edwards, Caitlin Gordon, Blessing Silaigwana, Roli Mathur

    Ethical considerations are an important part of decision-making processes at each stage of an infectious disease emergency. This chapter introduces the notion that ethical thinking begins with a process of clarification of the values and moral principles at work in decision-making, and evolves a set of procedures to reason morally in each decision-making context. Certain moral concepts are necessary to highlight in the ethics of infectious disease emergencies, particularly ideas of autonomy, beneficence, and justice. The chapter then works through the different phases of emergency response, introducing the key ethical issues and questions at each phase. Ethical thinking does not provide single ideal answers, but enables decision-makers to identify and articulate the value components of decisions, so as to balance, for example, considerations of individual liberties with public health outcomes in an emergency. Elaborate processes of consideration and consultation are often in tension with the challenges of making critical decisions rapidly and under uncertainty. That is why trustworthy institutions and continued community engagement are crucial, particularly in culturally diverse settings. The chapter concludes by emphasising the need for ongoing ethical reflection and preparedness to better manage future outbreaks, advocating for a sustained social conversation on the balance between protecting public health and respecting individual rights.

  • Open Access

    Research ethics during infectious disease outbreaks: A survey of African research stakeholders using the Ebola virus disease outbreak as a case

    by Raji Tajudeen, Blessing Silaigwana, Alexei Yavlinsky, Sarah J.L. Edwards

    Conducting research during disease outbreaks can be ethically challenging as evidenced in the 2014‑2016 Ebola outbreak in West Africa and COVID‑19 pandemic. Yet, there has been little empirical research conducted for understanding the views and perspectives of different stakeholders regarding ethical issues in conducting research during disease outbreaks. This preliminary study was conducted to empirically explore African public health research stakeholders' views about research ethics issues during infectious disease outbreaks in Africa. We conducted an online survey of 330 participants attending the International Conference on Re‑emerging and Emerging Infectious Disease (ICREID) meeting that took place from 13‑15 March 2019 in Addis Ababa, Ethiopia to elicit their views on various research ethics complexities experienced in the 2014 Ebola outbreak. Study results revealed some divergent views on several ethical themes including: ethics of using unregistered interventions in outbreaks; acceptable study design; ethics review processes; risks‑benefit assessment; exclusion of pregnant women and children; and biological sample and data sharing. Majority (76.3%) of respondents felt that in the absence of available standard treatments or prevention modalities, the use of investigational interventions can be ethically justifiable if there is a strong scientific rationale and favorable risk‑benefit ratio. Regarding conventional placebo‑controlled trials during outbreaks with high case fatality rates, respondents that considered this unethical were more than three times those that felt such design were ethically justifiable. We were somewhat surprised that a majority (almost 60%) of respondents were satisfied with the exclusion of pregnant women and children in clinical trials during outbreaks. All respondents concurred with the prioritization of informed consent for research during an outbreak. Based on our findings, research ethics guidance is needed to equip research stakeholders in dealing with ethical complexities arising in the conduct of research during emerging disease outbreaks‑especially regarding using experimental interventions; placebo trial design; inclusion or justified exclusion of pregnant women and children; and biological sample/data sharing. The findings will be used in ongoing efforts of developing a consultative and coherent African‑centric framework to support ethical conduct of research for future emerging infectious disease outbreaks in Africa.


  • Open Access

    An ethics of anthropology‐informed community engagement with COVID‐19 clinical trials in Africa

    by Sarah J. L. Edwards, Blessing Silaigwana, Danny Asogun, Julius Mugwagwa, Francine Ntoumi, Rashid Ansumana, Kevin Bardosh, Jennyfer Ambe

    The COVID‐19 pandemic has reinforced the critical role of ethics and community engagement in designing and conducting clinical research during infectious disease outbreaks where no vaccine or treatment already exists. In reviewing current practices across Africa, we distinguish between three distinct roles for community engagement in clinical research that are often conflated: 1) the importance of community engagement for identifying and honouring cultural sensitivities; 2) the importance of recognising the socio‐political context in which the research is proposed; and 3) the importance of understanding what is in the interest of communities recruited to research according to their own views and values. By making these distinctions, we show that current practice of clinical research could draw on anthropology in ways which are sometimes unnecessary to solicit local cultural values, overlook the importance of socio‐political contexts and wider societal structures within which it works, potentially serving to reinforce unjust political or social regimes, and threaten to cast doubt on the trustworthiness of the research. We argue that more discerning anthropological engagement as well as wider collaboration with other social scientists and those working in the humanities is urgently needed to improve the ethics of current biomedical and pharmaceutical research practice in Africa.